# Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection

> **NCT00734344** · NA · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 18 (actual)

## Conditions studied

- Acute HIV Infection

## Interventions

- **DRUG:** Raltegravir
- **DRUG:** Efavirenz
- **DRUG:** Emtricitibine
- **DRUG:** Tenofovir disoproxil once daily
- **DRUG:** Tenofovir disoproxil twice daily

## Key facts

- **NCT ID:** NCT00734344
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2012-08
- **Final completion:** 2012-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734344, "Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00734344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*